Brief: Lumos Pharma Reports Q3 2021 Financial Results
03/11/2021 21:24
Nov 3 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
AND
PROVIDES CLINICAL UPDATES
* QTRLY LOSS PER SHARE $0.90
* Q3 EARNINGS PER SHARE VIEW $-1.07 -- REFINITIV IBES DATA
* LUMOS PHARMA - CASH ON HAND AS OF END OF Q3 EXPECTED TO
SUPPORT
OPERATIONS THROUGH PRIMARY OUTCOME DATA READOUT FROM
ORAGROWTH210 AND ORAGROWTH212 TRIALS
Source text for Eikon: ID:nGNX2lVHxf
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)